Dna X (SONM) Gross Profit (2018 - 2025)

Dna X has reported Gross Profit for 8 years, with the latest figure at $1.8 million in Q3 2025.

• For the quarter ending Q3 2025, Gross Profit fell 57.09% year-over-year to $1.8 million; the trailing twelve-month figure through Sep 2025 stood at $10.8 million (down 28.83% YoY), and the FY2024 full-year result was $9.9 million, down 48.66% from the prior year.
• Gross Profit for Q3 2025 stood at $1.8 million, up from $845000.0 in the prior quarter.
• The five-year high for Gross Profit was $8.4 million in Q1 2025, with the low at -$487000.0 in Q4 2021.
• Historically, Gross Profit has averaged $3.1 million across 5 years, with a median of $2.9 million in 2024.
• Annual changes were most pronounced in 2021 — Gross Profit slumped 113.06% — and 2022, when it soared 907.39%.
• Dna X's Gross Profit stood at -$487000.0 in 2021, then soared by 907.39% to $3.9 million in 2022, then soared by 30.21% to $5.1 million in 2023, then slumped by 103.57% to -$183000.0 in 2024, then soared by 1092.35% to $1.8 million in 2025.
• The last three Gross Profit figures came in at $1.8 million (Q3 2025), $845000.0 (Q2 2025), and $8.4 million (Q1 2025), per Business Quant data.